Our drug development solutions for rare diseases
As a specialist clinical research organisation for rare disorders and diseases, we have extensive experience across a breadth of services — particularly in our key focus areas of oncology, neurological disorders, respiratory diseases, haematology, ophthalmological conditions, neonatology, hepatology and nephrology diseases.
Ultimately, our aim is to leverage our experience and expertise in rare diseases — partnering with you to bring potentially life-saving treatments to patients as cost-effectively and swiftly as possible.
We achieve this through our flexible, integrated and tailored services that span all the drug development phases, including regulatory affairs, pharmacovigilance, clinical development and combined medical services.
Our drug development solutions for rare diseases
Our services
Clinical services
We support clinical study development and delivery — across all phases of clinical trials globally — for rare conditions and diseases. We provide expert scientific and operational guidance throughout the drug development process to help you successfully deliver your clinical projects.
Medical services
We bridge the gap between clinical development, regulatory compliance and market access, supporting your journey throughout the drug life cycle by offering specialised medical services that ensure your product not only meets safety and efficacy standards but is also optimised for commercial success.